This brief underscores the history of GLP-1 medications and makes policy recommendations to ensure patients are receiving the right drugs at the right time.
Tag: prescription drugs / drug prices
By offering lower costs, more benefits and better outcomes, Medicare Advantage is increasingly becoming the Choice of America’s Seniors.
ACHP issued a statement in response to CMS’ CY 2025 Advance Notice for Medicare Advantage and Part D.
ACHP submitted a response to an RFI from the National Institute of Standards and Technology on the exercise of march-in rights.
ACHP submitted a response to an RFI from Senator Bill Cassidy (R-LA) on access to cell and gene therapies.